Crescent Capital Bdc Stock Buy Hold or Sell Recommendation

CCAP Stock  USD 19.22  0.16  0.84%   
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Crescent Capital BDC is 'Hold'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Crescent Capital BDC given historical horizon and risk tolerance towards Crescent Capital. When Macroaxis issues a 'buy' or 'sell' recommendation for Crescent Capital BDC, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out Crescent Capital Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
Note, we conduct extensive research on individual companies such as Crescent and provide practical buy, sell, or hold advice based on investors' constraints. Crescent Capital BDC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Execute Crescent Capital Buy or Sell Advice

The Crescent recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Crescent Capital BDC. Macroaxis does not own or have any residual interests in Crescent Capital BDC or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Crescent Capital's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Crescent CapitalBuy Crescent Capital
Hold

Market Performance

OKDetails

Volatility

Very steadyDetails

Hype Condition

Under hypedDetails

Current Valuation

OvervaluedDetails

Odds Of Distress

Very LowDetails

Economic Sensitivity

Follows the market closelyDetails

Investor Sentiment

ImpartialDetails

Analyst Consensus

Strong BuyDetails

Financial Strenth (F Score)

HealthyDetails

Financial Leverage

Not RatedDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails
For the selected time horizon Crescent Capital BDC has a Risk Adjusted Performance of 0.0904, Jensen Alpha of 0.0411, Total Risk Alpha of (0.02), Sortino Ratio of (0) and Treynor Ratio of 0.1728
Our trade advice tool can cross-verify current analyst consensus on Crescent Capital BDC and to analyze the company potential to grow in the current economic cycle. To make sure Crescent Capital is not overpriced, please confirm all Crescent Capital BDC fundamentals, including its gross profit, book value per share, and the relationship between the price to earning and cash per share . Given that Crescent Capital BDC has a number of shares shorted of 113.89 K, we suggest you to validate Crescent Capital BDC market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

Crescent Capital Trading Alerts and Improvement Suggestions

About 12.0% of the company shares are held by company insiders
Latest headline from news.google.com: Crescent Capital BDC, Inc. Given Consensus Recommendation of Moderate Buy by Brokerages - MarketBeat

Crescent Capital Returns Distribution Density

The distribution of Crescent Capital's historical returns is an attempt to chart the uncertainty of Crescent Capital's future price movements. The chart of the probability distribution of Crescent Capital daily returns describes the distribution of returns around its average expected value. We use Crescent Capital BDC price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Crescent Capital returns is essential to provide solid investment advice for Crescent Capital.
Mean Return
0.11
Value At Risk
-1.24
Potential Upside
1.48
Standard Deviation
0.92
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Crescent Capital historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Crescent Stock Institutional Investors

The Crescent Capital's institutional investors refer to entities that pool money to purchase Crescent Capital's securities or originate loans. These institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds.
Shares
Franklin Resources Inc2024-06-30
189.6 K
Hightower Advisors, Llc2024-06-30
141.1 K
Wells Fargo & Co2024-06-30
136.9 K
Blackrock Inc2024-06-30
135.5 K
Barclays Plc2024-06-30
131.2 K
Rockefeller Capital Management L.p.2024-06-30
118.6 K
Ubs Group Ag2024-06-30
111.8 K
Skandinaviska Enskilda Banken Ab2024-06-30
109.3 K
International Assets Investment Management, Llc2024-09-30
102.7 K
Texas County & District Retirement System2024-09-30
M
Fidelity National Title Group, Inc.2024-09-30
4.2 M
Note, although Crescent Capital's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Crescent Capital Cash Flow Accounts

201920202021202220232024 (projected)
Change In Cash3.1M1.4M8.7M(6.5M)7.4M7.8M
Net Borrowings87.5M66.3M161.4M21.1M24.3M23.1M
Free Cash Flow(203.0M)(61.8M)(157.7M)28.0M92.3M96.9M
Other Non Cash Items(232.3M)(118.2M)(235.9M)3.4M7.8M8.2M
Dividends Paid24.5M42.6M47.7M55.3M64.6M67.8M
Net Income29.3M54.7M83.6M15.5M83.8M88.0M
End Period Cash Flow13.4M14.8M23.5M17.1M24.5M15.0M
Change To Netincome(233.4M)(119.5M)(238.5M)59.7M68.7M72.1M
Depreciation(7.3T)(30.5M)(14.0B)48.0M(23.4M)(24.5M)

Crescent Capital Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Crescent Capital or Capital Markets sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Crescent Capital's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Crescent stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over Dow Jones
0.04
β
Beta against Dow Jones0.56
σ
Overall volatility
0.94
Ir
Information ratio -0.0027

Crescent Capital Volatility Alert

Crescent Capital BDC has low volatility with Treynor Ratio of 0.17, Maximum Drawdown of 4.08 and kurtosis of 3.61. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Crescent Capital's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Crescent Capital's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.

Crescent Capital Fundamentals Vs Peers

Comparing Crescent Capital's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Crescent Capital's direct or indirect competition across all of the common fundamentals between Crescent Capital and the related equities. This way, we can detect undervalued stocks with similar characteristics as Crescent Capital or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Crescent Capital's fundamental indicators could also be used in its relative valuation, which is a method of valuing Crescent Capital by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Crescent Capital to competition
FundamentalsCrescent CapitalPeer Average
Return On Equity0.13-0.31
Return On Asset0.0599-0.14
Profit Margin0.47 %(1.27) %
Operating Margin0.78 %(5.51) %
Current Valuation1.55 B16.62 B
Shares Outstanding37.06 M571.82 M
Shares Owned By Insiders12.49 %10.09 %
Shares Owned By Institutions48.58 %39.21 %
Number Of Shares Shorted113.89 K4.71 M
Price To Earning3.78 X28.72 X
Price To Book0.94 X9.51 X
Price To Sales3.52 X11.42 X
Revenue172.69 M9.43 B
Gross Profit116.72 M27.38 B
EBITDA84.11 M3.9 B
Net Income83.84 M570.98 M
Cash And Equivalents9.41 M2.7 B
Cash Per Share0.31 X5.01 X
Total Debt844.78 M5.32 B
Debt To Equity1.02 %48.70 %
Current Ratio1.14 X2.16 X
Book Value Per Share20.20 X1.93 K
Cash Flow From Operations92.3 M971.22 M
Short Ratio1.20 X4.00 X
Earnings Per Share2.56 X3.12 X
Price To Earnings To Growth0.89 X4.89 X
Target Price19.5
Beta0.87-0.15
Market Capitalization706.39 M19.03 B
Total Asset1.63 B29.47 B
Retained Earnings(223.34 M)9.33 B
Annual Yield0.11 %
Net Asset1.63 B
Note: Acquisition by Gerhard Lombard of 1500 shares of Crescent Capital at 18.275 subject to Rule 16b-3 [view details]

Crescent Capital Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Crescent . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Crescent Capital Buy or Sell Advice

When is the right time to buy or sell Crescent Capital BDC? Buying financial instruments such as Crescent Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Crescent Capital in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Investor Favorites Thematic Idea Now

Investor Favorites
Investor Favorites Theme
Macroaxis most traded equities with largest long positions over the last 2 years. The Investor Favorites theme has 21 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Investor Favorites Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Crescent Stock Analysis

When running Crescent Capital's price analysis, check to measure Crescent Capital's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Crescent Capital is operating at the current time. Most of Crescent Capital's value examination focuses on studying past and present price action to predict the probability of Crescent Capital's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Crescent Capital's price. Additionally, you may evaluate how the addition of Crescent Capital to your portfolios can decrease your overall portfolio volatility.